| Followers | 6 |
| Posts | 2155 |
| Boards Moderated | 0 |
| Alias Born | 11/26/2014 |
Monday, April 24, 2017 12:15:18 PM
1. First thing we need is Seroquel approval and commercialization.
2. Next, we need PAR to announce the release of remaining Focalin doses.
3. Pray for Pristiq and/or Lamictal approval. My guess is this will add about $2-3M per quarter but it would go straight to profit.
4. Gluco partner hopefully happens as well. That would be a nice adder to bottom line too. Not a lot of revenue because of off shore competition and low margins... But it would at least be something.
The Rexista lawsuit will drag on(I believe it is a stall tactic)... I am not expecting much on that front this year. But I am hoping IPCI can at least get profitable in 2017 and put dilution worries behind for good.
Recent IPCI News
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
